Merck Shares Jump 12.6% on Melanoma Vaccine Trial Results Merck & Co. (MRK) closed at $152.20 on Wednesday, August 19, 2026, up 12.60% (+$17.03) after…
Posts tagged as “MODERNA”
Moderna’s Historic Surge on Melanoma Vaccine Data Shares of Moderna (MRNA) soared 101% on Wednesday, August 19, 2026, marking the stock’s biggest intraday gain on…
Moderna more than Doubles on Late-Stage Melanoma Data Moderna (MRNA) shares surged 127.13% to $143.00 by noon EDT on Wednesday, August 19, 2026, after the…
Merck and Moderna reported positive top-line results from a Phase 3 trial of mRNA-4157 (V940), a personalized mRNA cancer vaccine, in patients with high-risk melanoma.…
$MRNA #Moderna #FDA #Vaccines FDA Signals Potential Approval for Moderna’s Flu Vaccine The U.S. Food and Drug Administration (FDA) has announced that it will review…